JPM vs RBB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
RBB Bancorp presents a complex value proposition with a stable Piotroski F-Score of 4/9 and a Graham Number of $35.54, suggesting significant defensive undervaluation. However, this is countered by a low growth-based intrinsic value of $12.81 and a bearish technical trend score of 10/100. While the company shows explosive YoY EPS growth and trades below book value (P/B 0.79), the low ROE of 6.2% and neutral insider sentiment suggest a lack of strong internal conviction. The stock is currently trading at a equilibrium point between its defensive fair value and its growth-based intrinsic value.
Compare Another Pair
Related Comparisons
JPM vs RBB: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and RBB Bancorp (RBB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.